484 followers
@grajohnt @eddit0r @SwiftOnSecurity Oxymetazoline is practically the same thing. So common here that the competitor formulation isn't worth marketing & selling. https://t.co/ur33L7XGFO
@grajohnt @eddit0r @SwiftOnSecurity Oxymetazoline is practically the same thing. So common here that the competitor formulation isn't worth marketing & selling. https://t.co/ur33L7XGFO